Figure 1
From: Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
Expression of IGFL2 between normal and tumor tissues (A) IGFL2 expression profiles from TIMER. (B) IGFL2 expression profiles from TCGA and GTEx databases. ***p < 0.001 **p < 0.01 *p < 0.05.
